Aging, estrogens, and episodic memory in women

Cognitive and Behavioral Neurology

Volumn 22, Issue 4, 2009, Pages 205-214

  Henderson, Victor W ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Alzheimer disease; Estrogens; Memory

Indexed keywords

CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; ESTRADIOL; ESTRIOL; ESTROGEN; ESTRONE; MEDROXYPROGESTERONE ACETATE; PLACEBO; RALOXIFENE; SEX HORMONE;

AGING; ALZHEIMER DISEASE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; DEMENTIA; DRUG MEGADOSE; EPISODIC MEMORY; ESTROGEN THERAPY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; LEARNING; MENOPAUSE; NONHUMAN; OVARIECTOMY; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW; TREATMENT DURATION; VERBAL MEMORY; DRUG EFFECT; FEMALE; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RECALL;

AGING; ALZHEIMER DISEASE; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; MENOPAUSE; MENTAL RECALL; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 73949123417     PISSN: 15433633     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNN.0b013e3181a74ce7     Document Type: Review

References (101)

1. Brown-Séquard CE. The effects produced on man by subcutaneous injections of a liquid obtained from the testicles of animals. Lancet. 1889;2:105-107.
2. Sengoopta C. The Most Secret Quintessence of Life. Sex, Glands and Hormones, 1850-1950. Chicago: University of Chicago Press; 2006:20-119.
3. Wilson RA. Feminine Forever. New York: M. Evans and Company; 1966.
4. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA. 2002;288:321-333.
5. Hersh AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA. 2004;291:47-53.
6. Kretz O, Fester L, Wehrenberg U, et al. Hippocampal synapses depend on hippocampal estrogen synthesis. J Neurosci. 2004;24: 5913-5921.
7. Hojo Y, Murakami G, Mukai H, et al. Estrogen synthesis in the brain-role in synaptic plasticity and memory. Mol Cell Endocrinol. 2008;290:31-43.
8. Shughrue PJ, Lane MV, Merchenthaler I. Comparative distribution of estrogen receptor-a and -b mRNA in the rat central nervous system. J Comp Neurol. 1997;388:507-525.
9. Milner TA, McEwen BS, Hayashi S, et al. Ultrastructural evidence that hippocampal alpha estrogen receptors are located at extranuclear sites. J Comp Neurol. 2001;429:355-371.
10. Milner TA, Ayoola K, Drake CT, et al. Ultrastructural localization of estrogen receptor beta immunoreactivity in the rat hippocampal formation. J Comp Neurol. 2005;491:81-95.
11. Shughrue PJ, Scrimo PJ, Merchenthaler I. Estrogen binding and estrogen receptor characterization (ERa and ERb) in the cholinergic neurons of the rat basal forebrain. Neuroscience. 2000;96:41-49.
12. Edwards DP. Regulation of signal transduction pathways by estrogen and progesterone. Annu Rev Physiol. 2005;67:335-376.
13. Squire LR, Stark CE, Clark RE. The medial temporal lobe. Annu Rev Neurosci. 2004;27:279-306.
14. Scoville WB. The limbic lobe in man. J Neurosurg. 1954;11:64-66.
15. Corkin S. Lasting consequences of bilateral medial temporal lobectomy: clinical course and experimental findings in H.M. Semin Neurol. 1984;4:249-259.
16. Storandt M. Longitudinal studies of aging and age-associated dementias. In: Boller F, Grafman J, eds. Handbook of Neuropsychology. Vol 4. New York: Elsevier; 1991:349-364.
17. Welsh K, Butters N, Hughes JP, et al. Detection and staging of dementia in Alzheimer's disease-use of the neuropsychological measures developed for the consortium to establish a registry for Alzheimer's disease. Arch Neurol. 1992;49:448-452.
18. Elias MF, Beiser A, Wolf PA, et al. The preclinical phase of Alzheimer's disease: a 22-year prospective study of the Framingham cohort. Arch Neurol. 2000;57:808-813.
19. Hyman BT, van Hoesen GW, Damasio AR, et al. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science. 1984;225:1168-1170.
20. Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303-308.
21. Trévoux R, De Brux J, Castanier M, et al. Endometrium and plasma hormone profile in the peri-menopause and postmenopause. Maturitas. 1986;8:309-326.
22. Henderson VW. Hormone Therapy and the Brain: A Clinical Perspective on the Role of Estrogen. New York: Parthenon Publishing; 2000.
23. Singh M, Meyer EM, Millard WJ, et al. Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats. Brain Res. 1994;644:305-312.
24. Fader AJ, Hendricson AW, Dohanich GP. Estrogen improves performance of reinforced T-maze alternation and prevents the amnestic effects of scopolamine administered systemically or intrahippocampally. Neurobiol Learn Mem. 1998;69:225-240.
25. Frye CA, Duffy CK, Walf AA. Estrogens and progestins enhance spatial learning of intact and ovariectomized rats in the object placement task. Neurobiol Learn Mem. 2007;88:208-216.
26. Zurkovsky L, Brown SL, Boyd SE, et al. Estrogen modulates learning in female rats by acting directly at distinct memory systems. Neuroscience. 2007;144:26-37.
27. Foy MR, Henderson VW, Berger TW, et al. Estrogen and neural plasticity. Curr Dir Psychol Sci. 2000;9:148-152.
28. Woolley CS, Gould E, Frankfurt M, et al. Naturally occurring fluctuation in dendritic spine density on adult hippocampal pyramidal neurons. J Neurosci. 1990;10:4035-4039.
29. Gould E, Woolley CS, Frankfurt M, et al. Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. J Neurosci. 1990;10:1286-1291.
30. Leranth C, Shanabrough M, Redmond DE Jr. Gonadal hormones are responsible for maintaining the integrity of spine synapses in the CA1 hippocampal subfield of female nonhuman primates. J Comp Neurol. 2002;447:34-42.
31. Tanapat P, Hastings NB, Reeves AJ, et al. Estrogen stimulates a transient increase in the number of new neurons in the dentate gyrus of the adult female rat. J Neurosci. 1999;19:5792-5801.
32. Luine V. Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp Neurol. 1985;89:484-490.
33. Schwarz JM, McCarthy MM. Cellular mechanisms of estradiolmediated masculinization of the brain. J Steroid Biochem Mol Biol. 2008;109:300-306.
34. Roof RL. Neonatal exogenous testosterone modifies sex difference in radial arm and Morris water maze performance in prepubescent and adult rats. Behav Brain Res. 1993;53:1-10.
35. Herman RA, Wallen K. Cognitive performance in rhesus monkeys varies by sex and prenatal androgen exposure. Horm Behav. 2007;51:139-142.
36. Protopopescu X, Butler T, Pan H, et al. Hippocampal structural changes across the menstrual cycle. Hippocampus. 2008; 18:985-988.
37. Phillips SM, Sherwin BB. Variations in memory function and sex steroid hormones across the menstrual cycle. Psychoneuroendocrinology. 1992;17:497-506.
38. Mordecai K, Rubin L, Maki P. Effects of menstrual cycle phase and oral contraceptive use on verbal memory. Horm Behav. 2008;54:286-293.
39. Maki PM, Rich JB, Rosenbaum RS. Implicit memory varies across the menstrual cycle: estrogen effects in young women. Neuropsychologia. 2002;40:518-529.
40. Epting LK, Overman WH. Sex-sensitive tasks in men and women: a search for performance fluctuations across the menstrual cycle. Behav Neurosci. 1998;112:1304-1317.
41. Henderson VW, Dudley EC, Guthrie JR, et al. Estrogen exposures and memory at midlife: a population-based study of women. Neurology. 2003;60:1369-1371.
42. Fuh J-L, Wang S-J, Lee S-J, et al. A longitudinal study of cognition change during early menopausal transition in a rural community. Maturitas. 2006;53:447-453.
43. Kok HS, Kuh D, Cooper R, et al. Cognitive function across the life course and the menopausal transition in a British birth cohort. Menopause. 2006;13:19-27.
44. Herlitz A, Thilers P, Habib R. Endogenous estrogen is not associated with cognitive performance before, during, or after menopause. Menopause. 2007;14:425-431.
45. Luetters C, Huang MH, Seeman T, et al. Menopause transition stage and endogenous estradiol and follicle-stimulating hormone levels are not related to cognitive performance: cross-sectional results from the study of women's health across the nation (SWAN). J Womens Health. 2007;16:331-344.
46. Mitchell ES, Woods NF. Midlife women's attributions about perceived memory changes: observations from the seattle midlife women's health study. J Womens Health Gend Based Med. 2001;10:351-362.
47. Drake EB, Henderson VW, Stanczyk FZ, et al. Associations between circulating sex steroid hormones and cognition in normal elderly women. Neurology. 2000;54:599-603.
48. Wolf OT, Kirschbaum C. Endogenous estradiol and testosterone levels are associated with cognitive performance in older women and men. Horm Behav. 2002;41:259-266.
49. Hogervorst E, De Jager C, Budge M, et al. Serum levels of estradiol and testosterone and performance in different cognitive domains in healthy elderly men and women. Psychoneuroendocrinology. 2004; 29:405-421.
50. Yaffe K, Barnes D, Lindquist K, et al. Endogenous sex hormone levels and risk of cognitive decline in an older biracial cohort. Neurobiol Aging. 2007;28:171-178.
51. Barrett-Connor E, Goodman-Gruen D. Cognitive function and endogenous sex hormones in older women. J Am Geriatr Soc. 1999;47:1289-1293. (Pubitemid 29523197)
52. Almeida OP, Lautenschlager N, Vasikaram S, et al. Association between physiological serum concentration of estrogen and the mental health of community-dwelling postmenopausal women age 70 years and over. Am J Geriatr Psychiatry. 2005;13:142-149.
53. den Heijer T, Geerlings MI, Hofman A, et al. Higher estrogen levels are not associated with larger hippocampi and better memory performance. Arch Neurol. 2003;60:213-220.
54. Berman KF, Schmidt PJ, Rubinow DR, et al. Modulation of cognition-specific cortical activity by gonadal steroids: a positronemission tomography study in women. Proc Natl Acad Sci USA. 1997;94:8836-8841.
55. Kaya E, Sahin FK, Köken G, et al. Acute effect of intranasal estrogen on cerebral and cerebellar perfusion in postmenopausal women. Maturitas. 2008;59:72-82.
56. Craig MC, Fletcher PC, Daly EM, et al. Physiological variation in estradiol and brain function: a functional magnetic resonance imaging study of verbal memory across the follicular phase of the menstrual cycle. Horm Behav. 2008;53:503-508.
57. Resnick SM, Maki PM, Golski S, et al. Effects of estrogen replacement therapy on PET cerebral blood flow and neuropsychological performance. Horm Behav. 1998;34:171-182.
58. Joffe H, Hall JE, Gruber S, et al. Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, doubleblind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women. Menopause. 2006;13:411-422.
59. Neele SJ, Rombouts SA, Bierlaagh MA, et al. Raloxifene affects brain activation patterns in postmenopausal women during visual encoding. J Clin Endocrinol Metab. 2001;86:1422-1424.
60. Henderson VW, Sherwin BB. Surgical versus natural menopause: cognitive issues. Menopause. 2007;14:572-579.
61. Hackman BW, Galbraith D. Replacement therapy with piperazine oestrone sulphate ("Harmogen") and its effect on memory. Curr Med Res Opin. 1976;4:303-306.
62. Vanhulle G, Demol R. A double-blind study into the influence of estriol on a number of psychological tests in post-menopausal women. In: van Keep PA, Greenblatt RB, Albeaux-Fernet M, eds. Consensus on Menopause Research: A Summary of International Opinion. Baltimore: University Park Press; 1976: 94-99.
63. Sherwin BB. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology. 1988;13:345-357.
64. Phillips SM, Sherwin BB. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology. 1992; 17:485-495.
65. Polo-Kantola P, Portin R, Polo O, et al. The effect of short-term estrogen replacement therapy on cognition: a randomized, doubleblind, cross-over trial in postmenopausal women. Obstet Gynecol. 1998;91:459-466.
66. Linzmayer L, Semlitsch HV, Saletu B, et al. Double-blind, placebocontrolled psychometric studies on the effects of a combined estrogen-progestin regimen versus estrogen alone on performance, mood and personality of menopausal syndrome patients. Arzneimittelforschung. 2001;51:238-245.
67. Dunkin J, Rasgon N, Wagner-Steh K, et al. Reproductive events modify the effects of estrogen replacement therapy on cognition in healthy postmenopausal women. Psychoneuroendocrinology. 2005; 30:284-296.
68. Maki PM, Gast MJ, Vieweg A, et al. Hormone therapy in menopausal women with cognitive complaints: a randomized, double-blind trial. Neurology. 2007;69:1322-1330.
69. Binder EF, Schechtman KB, Birge SJ, et al. Effects of hormone replacement therapy on cognitive performance in elderly women. Maturitas. 2001;38:137-146.
70. Grady D, Yaffe K, Kristof M, et al. Effect of postmenopausal hormone therapy on cognitive function: the heart and estrogen/ progestin replacement study. Am J Med. 2002;113:543-548.
71. Viscoli CM, Brass LM, Kernan WN, et al. Estrogen therapy and risk of cognitive decline: results from the women's estrogen for stroke trial (WEST). Am J Obstet Gynecol. 2005;192:387-393.
72. Wolf OT, Heinrich AB, Hanstein B, et al. Estradiol or estradiol/ progesterone treatment in older women: no strong effects on cognition. Neurobiol Aging. 2005;26:1029-1033.
73. Almeida OP, Lautenschlager NT, Vasikaran S, et al. 20-week randomized controlled trial of estradiol replacement therapy for women aged 70 years and older: effect on mood, cognition and quality of life. Neurobiol Aging. 2006;27:141-149.
74. Resnick SM, Maki PM, Rapp SR, et al. Effects of combination estrogen plus progestin hormone treatment on cognition and affect. J Clin Endocrinol Metab. 2006;91:1802-1810.
75. Yaffe K, Vittinghoff E, Ensrud KE, et al. Effects of ultra-low-dose transdermal estradiol on cognition and health-related quality of life. Arch Neurol. 2006;63:945-950.
76. Kjerulff K, Langenberg P, Guzinski G. The socioeconomic correlates of hysterectomies in the United States. Am J Public Health. 1994;83:106-108.
77. Davison S, Bell R, Donath S, et al. Androgen levels in adult females: changes with age, menopause and oophorectomy. J Clin Endocrinol Metab. 2005;90:3847-3853.
78. Sherwin BB, Tulandi T. "Add-back" estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri. J Clin Endocrinol Metab. 1996; 81:2545-2549.
79. Rocca WA, Bower JH, Ahlskog JE, et al. Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology. 2007;69:1074-1083.
80. Schiff R, Bulpitt CJ, Wesnes KA, et al. Short-term transdermal estradiol therapy, cognition and depressive symptoms in healthy older women. A randomised placebo controlled pilot cross-over study. Psychoneuroendocrinology. 2005;30:309-315.
81. Espeland MA, Rapp SR, Shumaker SA, et al. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA. 2004;291: 2959-2968.
82. Rossouw JE, Prentice RL, Manson JE, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA. 2007;297:1465-1477.
83. Clarkson TB. Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression. Menopause. 2007;14:373-384.
84. Umetani M, Domoto H, Gormley AK, et al. 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen. Nat Med. 2007;13:1185-1192.
85. Suzuki S, Brown CM, Dela Cruz CD, et al. Timing of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and antiinflammatory actions. Proc Natl Acad Sci U S A. 2007;104:6013-6018.
86. Shumaker SA, Legault C, Kuller L, et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA. 2004;291:2947-2958.
87. Paganini-Hill A, Henderson VW. Estrogen replacement therapy and risk of Alzheimer's disease. Arch Intern Med. 1996;156: 2213-2217. (Pubitemid 26361914)
88. Tang M-X, Jacobs D, Stern Y, et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet. 1996;348:429-432.
89. Kawas C, Resnick S, Morrison A, et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology. 1997;48:1517-1521.
90. Zandi PP, Carlson MC, Plassman BL, et al. Hormone replacement therapy and incidence of Alzheimer's disease on older women: the Cache County Study. JAMA. 2002;288:2123-2129.
91. Henderson VW, Benke KS, Green RC, et al. Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age. J Neurol Neurosurg Psychiatry. 2005;76:103-105.
92. Henderson VW. Estrogen-containing hormone therapy and Alzheimer's disease risk: understanding discrepant inferences from observational and experimental research. Neuroscience. 2006;138: 1031-1039.
93. Gibbs RB. Long-term treatment with estrogen and progesterone enhances acquisition of a spatial memory task by ovariectomized aged rats. Neurobiol Aging. 2000;21:107-116.
94. Daniel JM, Hulst JL, Berbling JL. Estradiol replacement enhances working memory in middle-aged rats when initiated immediately after ovariectomy but not after a long-term period of ovarian hormone deprivation. Endocrinology. 2006;147:607-614.
95. Rapp PR, Morrison JH, Roberts JA. Cyclic estrogen replacement improves cognitive function in aged ovariectomized rhesus monkeys. J Neurosci. 2003;23:5708-5714.
96. Lethaby A, Hogervorst E, Richards M, et al. Hormone replacement therapy for cognitive function in postmenopausal women. Cochrane Database Syst Rev. 2008;1:CD003122. doi: 10.1002/ 14651858.CD003122.pub2.
97. Brinton RD, Proffitt P, Tran J, et al. Equilin, a principal component of the estrogen replacement therapy Premarin, increases the growth of cortical neurons via an NMDA receptordependent mechanism. Exp Neurol. 1997;147:211-220.
98. Nilsen J, Brinton RD. Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogenactivated protein kinase signaling. Proc Natl Acad Sci U S A. 2003;100:10506-10511.
99. Rosario ER, Ramsden M, Pike CJ. Progestins inhibit the neuroprotective effects of estrogen in rat hippocampus. Brain Res. 2006;1099:206-210.
100. Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Control Clin Trials. 1998;19:61-109.
101. Yaffe K, Krueger K, Sarkar S, et al. Cognitive function in postmenopausal women treated with raloxifene. N Engl J Med. 2001;344:1207-1213.